Welcome to our dedicated page for Haleon SEC filings (Ticker: HLN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Haleon’s separation from GSK created a consumer-health giant with dozens of power brands—and a web of disclosures that can overwhelm even seasoned analysts. Sales are broken out across oral care, pain relief, vitamins and more, while its first standalone Form 20-F runs hundreds of IFRS-heavy pages. If you have ever asked, "Where do I find Haleon insider trading Form 4 transactions" or "How do I decode Haleon’s quarterly earnings report 10-Q filing?", you know the challenge.
Stock Titan solves it. Our AI reads every new filing the moment it hits EDGAR, then delivers plain-English summaries, red-flags and searchable key terms. Whether you need Haleon Form 4 insider transactions in real-time, a side-by-side view of segment revenue from the latest 6-K, or want Haleon SEC filings explained simply, the platform highlights what matters: advertising spend trends, litigation provisions, post-spin debt covenants and more. Long-tail queries such as "Haleon executive stock transactions Form 4", "understanding Haleon SEC documents with AI", or "Haleon earnings report filing analysis" resolve to the exact section—no scrolling required.
All filing types are here, updated continuously: the Haleon annual report 10-K simplified (20-F), Haleon proxy statement executive compensation, and every Haleon 8-K material events explained. Use our tools to:
- Track insider buying and selling before marketing launches
- Compare vitamin and mineral supplement growth quarter-over-quarter
- Spot supply-chain disclosures in material event filings
Haleon plc purchased 856,760 ordinary shares of £0.01 each for cancellation under the second tranche of its share buyback programme announced 31 July 2025. The purchases were executed on 08 August 2025 on the London Stock Exchange at prices between 353.5000p and 356.1000p, with a volume-weighted average price of 354.6173p.
Following settlement the company's registered share capital is 8,979,735,788 ordinary shares, of which 3,880,205 are held as treasury shares, leaving 8,975,855,583 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided RNS link and on Haleon's investor website.
Haleon plc (LSE/NYSE: HLN) filed a Form 6-K to report activity under the second tranche of its share-buyback programme announced on 31 July 2025. On 7 August 2025 the company purchased 1,330,960 ordinary shares (nominal £0.01) for cancellation on the London Stock Exchange at prices between 346.5p – 354.4p, delivering a volume-weighted average price of 351.6198p.
Post-settlement, Haleon’s registered share capital stands at 8,980,592,548 ordinary shares, of which 3,880,205 are held in treasury, leaving 8,976,712,343 voting shares outstanding. A detailed trade log is available via the RNS link and on the company’s investor website. No other material financial information or guidance is provided in this filing.
Haleon plc’s 7 Aug 2025 Form 6-K encloses a UK TR-1 notice showing Wellington Management Group LLP has fallen below the 5 % disclosure threshold.
- Date threshold crossed: 6 Aug 2025
- Current holding: 4.96 % of voting rights (445,697,628 votes)
- Prior holding: 5.29 %
- Break-down: 4.66 % ordinary shares (418.6 m votes), 0.29 % depositary receipts (26.4 m votes), 0.01 % cash-settled equity swaps (0.64 m votes)
- Change: roughly 0.33 ppt (≈28 m votes) disposed
The disclosure is mandatory under FCA DTR 5 and does not include earnings or operational updates. Investors may view the reduced stake as a marginal decline in long-only institutional ownership; however, no immediate strategic implications were provided.
Haleon plc has filed a Form 6-K outlining the latest activity under the second tranche of its share-buyback programme announced on 31 July 2025.
On 6 Aug 2025 the company repurchased 1,517,728 ordinary shares on the London Stock Exchange at a volume-weighted average price of 347.5568 p (high 350.3000 p, low 346.3000 p). No shares were bought on Cboe BXE or CXE. All acquired shares will be cancelled.
Post-transaction, Haleon’s issued share capital totals 8,981,923,508 shares of £0.01 each, with 3,880,205 held in treasury, leaving 8,978,043,303 voting shares outstanding. The purchase equates to roughly 0.017 % of shares in issue and does not materially alter the company’s capital structure.
No earnings figures, guidance, or other material financial disclosures accompany this filing. The update is chiefly administrative, confirming incremental progress toward the ongoing buyback plan.
On 05 Aug 2025, Haleon plc (HLN) filed a Form 6-K confirming execution of the second tranche of its share-buyback programme announced 31 Jul 2025. On 04 Aug 2025 the company repurchased 1,418,324 ordinary shares on the London Stock Exchange for cancellation. Purchase prices ranged from 355.90p to 364.60p, with a volume-weighted average of 358.534p. After settlement, issued share capital stands at 8,984,952,236 shares of £0.01 each; 3,880,205 shares are held in treasury, leaving 8,981,072,031 shares entitled to vote. A detailed trade log is available via the LSE RNS link and on Haleon’s investor site. No additional financial results or forward guidance were provided.
Haleon plc (HLN) Form 6-K: The company reports the purchase and cancellation of 1,281,000 ordinary shares (£0.01 par) on 1 Aug 2025, executed on the London Stock Exchange as part of the second tranche of its share-buyback programme announced 31 Jul 2025.
- Pricing: highest 368.4000p, lowest 359.0000p, volume-weighted average 364.8941p.
- The repurchase equals roughly 0.014% of the 8.98 bn shares outstanding.
- Post-settlement share capital totals 8,986,370,560, of which 3,880,205 are treasury shares, leaving 8,982,490,355 shares with voting rights.
The updated voting share count should be used for FCA disclosure thresholds. A trade-by-trade breakdown is available via the linked RNS PDF and on Haleon’s investor website. No additional financial or operational disclosures accompany this filing.
FAQ
What is the current stock price of Haleon (HLN)?
What is the market cap of Haleon (HLN)?
